TAIWAN · TWSE / TPEx
UniPharma
華宇藥 · 6621 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$11.851 month +3.0% · 1 year -4.4%
Directors and supervisors hold1,460,0174.1% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold6,270,00017.7% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 鄭明聰 | Chairman | — | 982,003 | 2.77% | — | — |
| 王愈善 | Director | 83,000 | 90,000 | 0.25% | — | — |
| 鄭宏泰 | Director | — | 0 | — | — | — |
| 蘇志宏 | Director | 379,014 | 388,014 | 1.09% | — | 179,000 |
| 簡合瑩 | Independent director | — | 0 | — | — | — |
| 陳建文 | Independent director | — | 0 | — | — | — |
| 李俊德 | Independent director | — | 0 | — | — | — |
| 戴國明 | President | — | 468,000 | 1.32% | — | — |
| 邱明善 | Vice president | — | 33,000 | 0.09% | — | — |
| 鄭巧蕾 | Assistant vice president | — | 4,000 | 0.01% | — | — |
| 健亞生物科技股份有限公司 | Major shareholder (10%+) | — | 6,270,000 | 17.66% | — | — |
| 馬銘襌 | Chief financial officer · Chief accountant | — | 0 | — | — | — |
| 陳正 | Other | — | 540,000 | 1.52% | — | — |